Ownership

Jeannette Potts - Insider Trading & Ownership

Entity: Individual
Location: C/O Forma Therapeutics Holdings, Inc., 500 Arsenal Street, Suite 100, Watertown, MA
Summary: The estimated net worth of Jeannette Potts is at least $1.23M dollars as of March 5, 2025. Jeannette Potts is the Chief Legal Officer of uniQure N.V. and owns shares of uniQure N.V. (QURE) stock worth about $1.23M.
All Insider Reports: All Insider Reports

Ownership of Jeannette Potts

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
QURE	uniQure N.V.	Chief Legal Officer	$1.23M	-$96.6K	-7.27%	Mar 3, 2025
FMTX	Forma Therapeutics Holdings, Inc.	Officer Title: SVP, General Counsel and Corporate Secretary				Oct 14, 2022

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Jeannette Potts:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
QURE	uniQure N.V.	Ordinary Shares	Sale	-5.58%	-$72.8K	10.29	-7.08K	120K	3/4/2025	Direct
QURE	uniQure N.V.	Ordinary Shares	Award	+38.1%	$0	0.00	+35K	127K	3/3/2025	Direct
QURE	uniQure N.V.	Stock Option (Right to Buy)	Award		$0	0.00	+60K	60K	3/3/2025	Direct
QURE	uniQure N.V.	Ordinary Shares	Sale	-4.95%	-$23.8K	4.98	-4.78K	91.8K	6/13/2024	Direct
QURE	uniQure N.V.	Ordinary Shares	Award	+105.1%	$0	0.00	+49.5K	96.6K	3/1/2024	Direct
QURE	uniQure N.V.	Stock Option (Right to Buy)	Award		$0	0.00	+85.5K	85.5K	3/1/2024	Direct
QURE	uniQure N.V.	Ordinary Shares	Award		$0	0.00	+47.1K	47.1K	6/13/2023	Direct
QURE	uniQure N.V.	Option (Right to Buy)	Award		$0	0.00	+81.3K	81.3K	6/13/2023	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%	$0		-47.4K	0	10/14/2022	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Disposed to Issuer	-100%	$0		-382K	0	10/14/2022	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Common Stock	Award	+111.8%	$0	0.00	+25K	47.4K	2/28/2022	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+37.5K	37.5K	2/28/2022	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Common Stock	Sale	-17.3%	-$45.7K	9.78	-4.67K	22.4K	2/23/2022	Direct

Showing 1 to 13 of 13 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.